Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A screening method for the detection of the 35S promoter and the nopaline synthase terminator in genetically modified organisms in a real-time multiplex polymerase chain reaction using high-resolution melting-curve analysis.
Akiyama H, Nakamura F, Yamada C, Nakamura K, Nakajima O, Kawakami H, Harikai N, Furui S, Kitta K, Teshima R. Akiyama H, et al. Among authors: kawakami h. Biol Pharm Bull. 2009 Nov;32(11):1824-9. doi: 10.1248/bpb.32.1824. Biol Pharm Bull. 2009. PMID: 19881291 Free article.
Precision engineered peptide targeting leukocyte extracellular traps mitigate acute kidney injury in Crush syndrome.
Okubo K, Takayama K, Kawakami H, Iida K, Miyauchi H, Roppongi Y, Ikeyama H, Hayashi M, Fujishima S, Sasaki J, Haruta J, Hayashi Y, Hirahashi J. Okubo K, et al. Among authors: kawakami h. Biochem Biophys Res Commun. 2023 Sep 3;671:173-182. doi: 10.1016/j.bbrc.2023.06.013. Epub 2023 Jun 5. Biochem Biophys Res Commun. 2023. PMID: 37302292 Free article.
Multiple site inflammation and acute kidney injury in crush syndrome.
Miyauchi H, Okubo K, Iida K, Kawakami H, Takayama K, Hayashi Y, Haruta J, Sasaki J, Hayashi K, Hirahashi J. Miyauchi H, et al. Among authors: kawakami h. Front Pharmacol. 2024 Aug 30;15:1458997. doi: 10.3389/fphar.2024.1458997. eCollection 2024. Front Pharmacol. 2024. PMID: 39281284 Free PMC article.
Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.
Bass-Stringer S, Bernardo BC, Yildiz GS, Matsumoto A, Kiriazis H, Harmawan CA, Tai CMK, Chooi R, Bottrell L, Ezeani M, Donner DG, D'Elia AA, Ooi JYY, Mellett NA, Luo J, Masterman EI, Janssens K, Olshansky G, Howden EJ, Cross JH, Hagemeyer CE, Lin RCY, Thomas CJ, Magor GW, Perkins AC, Marwick TH, Kawakami H, Meikle PJ, Greening DW, Weeks KL, La Gerche A, Tham YK, McMullen JR. Bass-Stringer S, et al. Among authors: kawakami h. J Sport Health Sci. 2025 Jan 16:101023. doi: 10.1016/j.jshs.2025.101023. Online ahead of print. J Sport Health Sci. 2025. PMID: 39826614
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.
Siena S, Raghav K, Masuishi T, Yamaguchi K, Nishina T, Elez E, Rodriguez J, Chau I, Di Bartolomeo M, Kawakami H, Suto F, Koga M, Inaki K, Kuwahara Y, Takehara I, Barrios D, Kobayashi K, Grothey A, Yoshino T. Siena S, et al. Among authors: kawakami h. Nat Commun. 2025 Jan 15;16(1):704. doi: 10.1038/s41467-025-56170-9. Nat Commun. 2025. PMID: 39814812 Free PMC article. No abstract available.
1,507 results